Press Releases | Medtronic

Month Year

Email alerts

Aug 20, 2011

Medical Device Recipient Successfully Crosses English Channel to Raise Money for ALS (Lou Gehrig's Disease)

MEMPHIS, Tenn., Aug 22, 2011 (BUSINESS WIRE) -- Medtronic (NYSE: MDT) announced cervical disc recipient Doug McConnell successfully completed his swim across the English Channel today. McConnell,...
Aug 18, 2011

Medtronic Gains CE Mark for 31mm CoreValve(R) Percutaneous Aortic Valve

New Offering Provides Therapy Option to Previously Unserved Patients with Larger Aortic Valves

MINNEAPOLIS, Aug 18, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for its 31mm Medtronic CoreValve(R) System, the only...
Aug 15, 2011

Study Shows Medtronic InterStim(R) Therapy Improves Bowel Control and Related Quality of Life Issues at Three Years

InterStim Therapy for Bowel Control Recently Approved by the U.S. FDA

MINNEAPOLIS, Aug 15, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today that newly published data from a multicenter, prospective trial show that sacral nerve stimulation using...
Aug 12, 2011

Medtronic to Announce Financial Results for Its First Quarter of the Fiscal Year 2012

MINNEAPOLIS, Aug 12, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2012 on Tuesday, August 23, 2011....
Aug 5, 2011

Medtronic to Webcast Annual Shareholder Meeting

MINNEAPOLIS, Aug 05, 2011 (BUSINESS WIRE) -- Medtronic investors and other interested parties are invited to participate in a live video webcast of the Medtronic Annual Shareholder Meeting on...
Aug 3, 2011

Medtronic Engages Yale University to Oversee Independent, Systematic Reviews of Recombinant Bone Morphogenic Protein-2

First of its Kind Post-Review Website to Provide Scientific Access to Full Clinical Data

MINNEAPOLIS, Aug 03, 2011 (BUSINESS WIRE) -- Medtronic, Inc. [NYSE: MDT] announced today that it has provided a grant to Yale University to conduct two fully independent, third-party systematic...
Aug 1, 2011

Medtronic Receives FDA Approval for Advisa DR MRI(TM) SureScan(R) Pacing System Clinical Trial

Investigational Second-Generation Device Reinforces Medtronic's Commitment to Innovative Implantable Cardiac Devices Designed for Use in MRI Environment

MINNEAPOLIS, Aug 01, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...
Jul 25, 2011

Medtronic Resolute(R) Drug-Eluting Stent Shows Superiority to Taxus(R) DES in Study of Patients with Coronary Artery Disease

Presented at CVIT by Principal Investigator Shigeru Saito, One-Year Data from RESOLUTE Japan Support Company's PMDA Submission for Product Approval

MINNEAPOLIS, Jul 25, 2011 (BUSINESS WIRE) -- TheResolute(R) drug-eluting stent (DES) from Medtronic, Inc. (NYSE: MDT), showed superiority to Boston Scientific Corp.'s Taxus(R) DES on the primary...
Jul 21, 2011

Medtronic Announces 2011 "Global Heroes"

Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall

MINNEAPOLIS, Jul 21, 2011 (BUSINESS WIRE) -- Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run the Medtronic Twin...
Jul 11, 2011

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Patient Enrollment in U.S. Clinical Trial of Renal Denervation with Symplicity(R) Catheter System(TM) for Treating Resistant Hypertension to Start Soon

MINNEAPOLIS, Jul 11, 2011 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT), announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY...

Show per page